InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Goldstein Dov A Md, Director. Director active across 4 companies, notably NeuBase Therapeutics, Inc.. Aggregated, 10 filings have been published. Split: 2 buys · 1 sell. Total volume traded: €32k. Activity tracked since 18 June 2021. The latest transaction was filed on 23 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Goldstein Dov A Md
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
3,542 shares@ US$4.380.0014% mcap100.0% of flowCommon StockSEC:0001120478-26-000013:0
3,542 shares@ US$4.385.3% of flowCommon StockSEC:0001120478-26-000011:0
3,541 shares@ US$4.385.2% of flowCommon StockSEC:0001120478-26-000007:0
3,542 shares@ US$4.385.4% of flowCommon StockSEC:0001120478-26-000005:0
27,000 shares@ US$8.3978.6% of flowCommon StockSEC:0001120478-26-000003:0
17,557 shares@ US$1.09100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001641172-25-024820:0
10,000 sharesCommon Stock, par value $0.0001 per shareSEC:0001493152-23-000221:0
Canonical exit: 3 Apr 2023 (T+90)
8,000 shares@ US$4.75100.0% of flowCommon StockSEC:0001104659-21-083253:0
Canonical exit: 16 Sept 2021 (T+90)
842 sharesCommon StockSEC:0000950142-16-002788:0
842 sharesCommon StockSEC:0000950142-16-002788:1
10 of 10 declarations
About Goldstein Dov A Md
Administrateur, GOLDSTEIN DOV A MD has 10 filings in total. Across the 10 recent sampled filings, the period runs from 2016-01-06 to 2026-04-24, with buys of EUR 31897 and no sells, and the most common transaction type is option exercise. He is linked to BioAge Labs, Inc., Coya Therapeutics, Inc., CEMPRA, INC., and NeuBase Therapeutics, Inc.
